| Literature DB >> 34862569 |
Rui Wang1, Yaodong Ding1, Jiaxin Yang1, Kexin Wang1, Wen Gao2, Zhe Fang3, Yujie Zhou1, Hailong Ge4.
Abstract
OBJECTIVE: This study was aimed to compare different stenting techniques for coronary bifurcation disease (CBD).Entities:
Keywords: Coronary bifurcation disease; Network meta-analysis; Stenting techniques
Mesh:
Year: 2021 PMID: 34862569 PMCID: PMC9242927 DOI: 10.1007/s00392-021-01979-9
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 6.138
Fig. 1Study flow diagram
Clinical, angiographic, and procedural characteristics
| Study | Year | Intervention | Sample size | Age | Sex male | Hyperlipidemia | Hypertension | Diabetes mellitus | Prior MI |
|---|---|---|---|---|---|---|---|---|---|
| Colombo et al. | 2004 | T/TAP vs. provisional | 86 | 63 ± 10 62 ± 9 | 48 (76) 21 (91) | NA | NA | 13 (21) 6 (26) | NA |
| Pan et al. | 2004 | Provisional vs. T/TAP | 91 | 61 ± 10 58 ± 11 | 34 (72) 38 (86) | 25 (53) 18 (41) | 28 (59) 25 (57) | 20 (42) 17 (39) | 9 (19) 17 (39) |
| DKCRUSH-1 | 2008 | Crush vs DK crush | 311 | 64 ± 9 64 ± 9 | 109 (70) 118 (76) | 98 (63) 106 (69) | 120 (77) 118 (76) | 13 (8) 42 (27) | 19 (12) 13 (9) |
| CACTUS | 2009 | Crush vs. provisional | 350 | 65 ± 10 67 ± 10 | 142 (80) 132 (76) | 113 (64) 122 (71) | 125 (71) 138 (80) | 42 (24) 38 (22) | 79 (45) 61 (35) |
| THUEBIS | 2009 | Dedicated vs. provisional | 110 | 67 ± 9 65 ± 11 | 40 (71) 42 (78) | 28 (50) 35 (67) | 49 (88) 42 (78) | 14 (25) 14 (26) | NA |
| BBC ONE | 2010 | Provisional vs crush | 500 | 64 ± 10 64 ± 11 | 192 (77) 193 (77) | 188 (76) 189 (76) | 142 (57) 157 (62) | 31 (13) 29 (11) | 57 (23) 63 (25) |
| Lin et al. | 2010 | Provisional vs. DK crush | 108 | 61 ± 7 59 ± 7 | 45 (83) 41 (76) | NA | 49 (91) 45 (83) | 10 (19) 7 (13) | 12 (22) 10 (19) |
| Ye et al. | 2010 | DK crush vs. provisional | 51 | 64 ± 12 63 ± 10 | 16 (64) 19 (73) | 4 (16) 3 (12) | 19 (76) 19 (73) | 4 (16) 5 (19) | NA |
| Ye et al. | 2012 | DK crush vs. provisional | 68 | 64 ± 11 62 ± 10 | 24 (63) 23 (77) | 7 (18) 6 (20) | 29 (76) 20 (67) | 7 (18) 4 (13) | 4 (11) 2 (7) |
| NSTS | 2013 | Crush vs. culotte | 424 | 65 ± 10 65 ± 11 | 149 (71) 154 (71) | 176 (84) 159 (74) | 130 (62) 129 (60) | 28 (13) 31 (15) | NA |
| NBS | 2013 | Provisional vs crush | 404 | 63 ± 10 63 ± 10 | 154 (76) 158 (78) | 158 (78) 146 (72) | 109 (54) 117 (58) | 26 (13) 24 (12) | NA |
| Ruiz et al. | 2013 | Provisional vs. T/TAP | 69 | 63 ± 13 64 ± 13 | 28 (85) 28 (78) | 17 (51) 23 (64) | 22 (67) 26 (72) | 15 (45) 12 (33) | NA |
| DKCRUSH-III | 2015 | DK crush vs. culotte | 419 | 64 ± 10 63 ± 9 | 162 (77) 167 (80) | 87 (41) 88 (42) | 148 (71) 128 (61) | 67 (32) 63 (30) | NA |
| BBK I | 2015 | Provisional vs. T/TAP | 202 | 67 ± 10 67 ± 11 | 80 (79) 79 (78) | NA | 93 (92) 90 (89) | 26 (26) 19 (19) | 19 (19) 21 (21) |
| TRYTON | 2015 | Dedicated vs. provisional | 704 | 65 ± 11 65 ± 9 | 255 (72) 256 (73) | 260 (74) 266 (77) | 260 (73) 256 (74) | 85 (24) 98 (28) | 105 (30) 131 (38) |
| PERFECT | 2015 | Crush vs. provisional | 419 | 61 ± 9 61 ± 9 | 160 (75) 155 (75) | 132 (62) 118 (57) | 118 (55) 114 (55) | 55 (26) 60 (29) | 9 (4) 9 (4) |
| BBK II | 2016 | Culotte vs T/TAP | 300 | 66 ± 11 69 ± 10 | 107 (71) 114 (76) | NA | 132 (88) 128 (85) | 41 (27) 42 (28) | 24 (16) 32 (21) |
| EBC TWO | 2016 | Provisional vs. culotte | 200 | 63 ± 11 64 ± 12 | 87 (85) 76 (78) | 72 (70) 70 (70) | 65 (63) 66 (68) | 26 (25) 30 (31) | 40 (39) 40 (41) |
| SMART | 2016 | Provisional vs. T/TAP | 258 | 62 ± 10 62 ± 10 | 105 (82) 108 (83) | 16 (13) 17 (13) | 70 (55) 75 (58) | 37 (29) 33 (25) | 7 (6) 5 (4) |
| Zhang et al. | 2016 | Provisional vs. culotte | 104 | 65 ± 11 64 ± 7 | 48 (92) 43 (83) | 6 (12) 6 (12) | 35 (67) 33 (64) | 10 (19) 11 (21) | 12 (23) 10 (19) |
| Zheng et al. | 2016 | Crush vs. culotte | 300 | 63 ± 8 64 ± 9 | 109 (73) 111 (74) | 114 (76) 105 (70) | 106 (71) 109 (73) | 33 (22) 37 (25) | NA |
| DKCRUSH-II | 2017 | DK crush vs. provisional | 366 | 64 ± 11 65 ± 10 | 145 (79) 138 (76) | 62 (34) 53 (30) | 120 (65) 111 (61) | 36 (20) 42 (23) | 32 (17) 24 (14) |
| COBRA | 2018 | Dedicated vs. culotte | 40 | 66 ± 9 64 ± 10 | 14 (70) 15 (75) | 19 (95) 19 (95) | 15 (75) 14 (70) | 5 (25) 4 (20) | 6 (30) 2 (10) |
| DKCRUSH-V | 2019 | Provisional vs. DK crush | 482 | 64 ± 10 65 ± 9 | 188 (78) 199 (83) | 115 (48) 114 (48) | 156 (65) 175 (73) | 62 (26) 69 (29) | 51 (21) 52 (22) |
| POLBOS I | 2020 | Dedicated vs provisional | 243 | 66 ± 11 66 ± 9 | 82 (68) 84 (68) | 75 (63) 70 (57) | 94 (78) 90 (73) | 45 (38) 31 (25) | 55 (46) 43 (35) |
| POLBOS II | 2020 | Dedicated vs provisional | 202 | 67 ± 9 67 ± 9 | 78 (76) 75 (75) | 85 (83) 81 (81) | 86 (84) 81 (81) | 45 (44) 32 (33) | 44 (43) 48 (48) |
| NBBS IV | 2020 | Provisional vs. culotte | 446 | 64 ± 12 63 ± 11 | NA | 178 (82) 184 (81) | 152 (70) 149 (66) | 36 (17) 35 (16) | NA |
T/TAP T-stenting/T-stenting and protrusion, DK double kissing, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, LVEF left-ventricular ejection fractions
Fig. 2Network plot. DK double kissing, TSTE/TAP T-stenting/T-stenting and protrusion
Fig. 3Direct pair-wise comparison for MACEs of 26 trails. TAP T-stenting and protrusion, DK double kissing
Network meta-analysis for primary and secondary endpoints
Results are the ORs in the column-defining treatment compared with the ORs in the row-defining treatment. For outcomes, ORs higher than 1 favor the row-defining treatment. Significant results are in bold and underscored
TAP T-stenting and protrusion, DK double kissing, MACE major adverse cardiovascular event, MI myocardial infarction, TLR target-lesion revascularization, ST stent thrombosis
Fig. 4Node-splitting analysis. DK double kissing, TAP T-stenting and protrusion. ORs higher than 1 favor the prior treatment. P value which is greater than 0.05 is considered no inconsistency
Fig. 5Rank probability analysis for primary and secondary endpoints. DK double kissing, TAP T-stenting and protrusion. Rank 1 is identified as the treatment with the highest incidence of each endpoint events and Rank 6 is identified as the treatment with the lowest incidence of each endpoint event
Network meta-analysis for primary and secondary endpoints in patients with complex bifurcation lesions defined by DEFINITION criterion
Results are the ORs in the column-defining treatment compared with the ORs in the row-defining treatment. For outcomes, ORs higher than 1 favor the row-defining treatment. Significant results are in bold and underscored
TAP T-stenting and protrusion, DK double kissing, MACE major adverse cardiovascular event, MI myocardial infarction, TLR target-lesion revascularization, ST stent thrombosis
Fig. 6Forest plot for MACEs in patients with complex bifurcation lesions defined by DEFINITION criterion. MACE major adverse cardiovascular event, DK double kissing, TAP T-stenting and protrusion
Fig. 7Rank probability analysis in patients with complex bifurcation lesions. DK double kissing, TAP T-stenting and protrusion, MACE major adverse cardiovascular event, MI myocardial infarction, TLR target-lesion revascularization, ST stent thrombosis. Rank 1 is identified as the treatment with the highest incidence of each endpoint events and Rank 4 is identified as the treatment with the lowest incidence of each endpoint events